Jonathan Steckbeck

Jonathan Steckbeck, PhD, MBA, is the founder and CEO of Peptilogics, a clinical stage biotechnology platform company pioneering the development of best-in-class novel peptide therapeutics. Under his leadership, Peptilogics has developed a computational drug discovery platform to speed the design and development of novel peptide drugs across a range of therapeutic targets. The company is now rapidly advancing a pipeline of anti-infective therapies in focused indications and expanding the application of its platform to new disease areas. Jonathan has a PhD in Biochemistry and Molecular Genetics and an MBA from the University of Pittsburgh.